Pharmacokinetics and tolerability of the T-type calciumchannel blocker act-709478, a potentialnewantiepileptic drug, in a single-ascending dose study in healthy subjects

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2018
This article has no abstract
Epistemonikos ID: afaab8b28691b81b9211f06237afd56e3022fe1d
First added on: Apr 29, 2026